A new cytotoxic phenylbutenoid dimer from the rhizomes of Zingiber cassumunar

College of Pharmacy, Ewha Womans University, Seoul, Korea.
Planta Medica (Impact Factor: 2.34). 12/2004; 70(11):1095-7. DOI: 10.1055/s-2004-832656
Source: PubMed

ABSTRACT A new phenylbutenoid dimer, (+/-)- trans-3-(4-hydroxy-3-methoxyphenyl)-4-[(E)-3,4-dimethoxystyryl]cyclohex-1-ene, was isolated from the rhizomes of Zingiber cassumunar along with the three known compounds, (+/-)- trans-3-(3,4-dimethoxyphenyl)-4-[(E)-3,4-dimethoxystyryl]cyclohex-1-ene, 4-(3,4-dimethoxyphenyl)but-1,3-diene, and 4-(2,4,5-trimethoxyphenyl)but-1,3-diene by bioassay-directed fractionation using the A549 human cancer cell line cytotoxicity assay. Structure of the new compound was elucidated by spectral analysis, including 1D and 2D NMR experiments.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Epitaxially twinned (028)-oriented Bi3.25La0.75Ti3O12 (BLT) thin films were grown on GaN(002)/Al2O3 (0006) substrates by pulsed laser deposition. The BLT layer deposited on GaN substrate showed sixfold-like symmetric peaks in a φ scan of (006) reflection and 12 peaks in that of the (117) reflection. In order to investigate hetero-epitaxial growth, origin of six and 12 peaks in the φ scan, and the domain structure of the BLT thin film, the X-ray analysis including θ–2θ, ω, φ scan, and pole figure measurement were performed. The hetero-epitaxial growth was studied by atomic arrangements and domain distribution with calculated lattice mismatch, interplanar angles, and atomic distances.
    Journal of Crystal Growth 10/2004; 271(1):50-54. DOI:10.1016/j.jcrysgro.2004.07.020 · 1.69 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Straightforward and facile synthesis of a bioactive component A from Zingiber cassumunarRoxb. is described. The phenylbutenoid dimer A was reported to possess anti-inflammatory and cytotoxic activities. The optically active cyclohexene ring fragment was obtained via the highly diastereo- and enantioselective Diels–Alder reaction of chiral acryloyloxazolidinones (1a and 1b) and 1-(4-hydroxy-3-methoxyphenyl)butadiene (2). The enantiomeric excess of Diels–Alder adducts 3a and 3bwere determined via high-performance liquid chromatotography of the corresponding bis-acetate (6). The greatest enantiomeric excess (99.9% ee) was obtained when the 4-phenyloxazolidin-2-one (1a) chiral auxiliary was used in combination with TiCl4. The optically pure bioactive compound A was prepared from the optically active Diels–Alder adduct (3a) in two additional steps.
    Synthetic Communications 03/2014; 44(9). DOI:10.1080/00397911.2013.846380 · 0.98 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The expression of P-glycoprotein (P-gp), an ATP-dependent efflux transporter, is closely associated with the failure of chemotherapy and drug absorption. Two synthesized optically active phenylbutenoid dimers, 3S-(3,4-dimethoxyphenyl)-4R-{(E)-3,4-dimethoxystyryl}cyclohex-1-ene (1) and 3R-(3,4-dimethoxyphenyl)-4S-{(E)-3,4-dimethoxystyryl}cyclohex-1-ene (2), were tested for their P-gp inhibitory effects by measuring cellular accumulation and efflux of daunomycin in P-gp-overexpressed human breast cancer cells (MCF-7/ADR). Compound 2 significantly increased the accumulation of daunomycin (539%) and decreased the efflux of this compound (55.4%), and similar results were observed for 1. ATPase assays and Western blot analysis were performed to identify the mechanisms by which compounds 1 and 2 inhibit P-gp. In addition, changes in the pharmacokinetic profile of paclitaxel coadministered with 2 in rats were evaluated. Paclitaxel (25 mg/kg) when orally administered with 2 (5 mg/kg) improved its relative bioavailability by 185%. Compound 2 effectively improved cellular accumulation by reducing the efflux of daunomycin and significantly enhanced oral exposure to paclitaxel. Therefore, compound 2 may be useful for improving oral exposure and cellular availability of drugs that are also substrates of P-gp.
    Journal of Natural Products 11/2013; 76(12). DOI:10.1021/np4004917 · 3.95 Impact Factor